RJA
UBX

Raymond James & Associates’s Unity Biotechnology UBX Stock Holding History

Raymond James & Associates’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,275
Closed -$380K – 3590
2019
Q4 		$380K Buy
+5,275
New +$380K ﹤0.01% 2915